Abiopharma

New Form SCHEDULE 13G/A - Roman DBDR Acquisition Corp. II <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003560 <b>Size:</b> 7 KB

General Announcement: Payment of Interest in respect of 2025 Third Tranche Medium Term Notes

(10% Negative) TVARDI THERAPEUTICS, INC. (TVRD) Reports Q3 2026 Financial Results

New Form SCHEDULE 13G/A - BioXcel Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003557 <b>Size:</b> 10 KB

New Form SCHEDULE 13G/A - STAAR SURGICAL CO <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001013594-26-000899 <b>Size:</b> 14 KB

Saputo Enters Agreement to Sell its United Kingdom Operations

Saputo conclut une entente en vue de la vente de ses activités au Royaume-Uni

Saputo Enters Agreement to Sell its United Kingdom Operations

📋 Groner Gili (Officer) plans to sell 27K shares of Allot Ltd. (at $7.93 each, total $211K) Filed: Aug 14, 2026 | ID: 000734

New Form SCHEDULE 13G - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003556 <b>Size:</b> 10 KB

New Form SCHEDULE 13G/A - GAIA, INC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-350838 <b>Size:</b> 119 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001918704-26-023763 <b>Size:</b> 577 KB

New Form SCHEDULE 13G/A - Biodexa Pharmaceuticals Plc <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003555 <b>Size:</b> 10 KB

Financial Statements and Related Announcement: Half Yearly Results

New Form SCHEDULE 13G/A - BICYCLE THERAPEUTICS PLC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003554 <b>Size:</b> 10 KB